XML 246 R99.htm IDEA: XBRL DOCUMENT v3.26.1
Sale of RPK - Schedule of Consolidated Statements of Loss and Comprehensive Loss (Details) - Bophelo Bio Science and Wellness (Pty) Ltd. ("Bophelo") - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2022
Schedule of Consolidated Statements of Loss and Comprehensive Loss [Line Items]      
Cash received $ 2,000,000 $ 2,000,000  
Finder’s fee – transaction cost (446,250) (446,250)  
Consideration received, net 1,553,750 1,553,750  
Cash 105,175 105,175 $ 739,947
Accounts receivable 158,812 158,812  
Inventory 895,715 895,715  
Prepayments 33,762 33,762  
Property, plant and equipment, net 1,769,221 1,769,221  
Intangible licenses 3,783,117 3,783,117  
Accounts payable (2,016,744) (2,016,744)  
Bank loans (3,374,088) (3,374,088)  
Net assets sold 1,354,970 1,354,970  
Gain on sale of subsidiary $ 198,780 $ 198,780 $ 2,085,624